| |
| | '+alt+' |
 | | As already suggested, glass delamination in pharmaceutical vials can occur during manufacturing of the vial, e.g. |
 | | fusion at the neck or base, where delamination and/or pitting are frequently found; or by adverse reaction to the vial contents, e.g. |
 | | For confidentiality purposes, the manufacturers will be referred to as Company A, B, and C. In addition to determining the amount of glass delamination, further analysis was requested for Company B only, due to an unusual vertical-striation appearance. |
| www.modernmicroscopy.com /main.asp?article=19 (108 words) |
|